Alpha Sense BI

DECEMBER 26, 2023

Over the last 12-18 months, both venture capital investors and start-up firms have felt the aftershocks of ongoing economic volatility. Following a ‘dry powder’ run in 2021, venture capital investment in the US nearly doubled from 2020. Similar to other asset classes, venture capital deal patterns mirror macroeconomic sentiment.

Due Diligence 59

Due Diligence Capital Algorithm Banking 59

Evalueserve

DECEMBER 6, 2021

Within the healthcare industry, healthcare equipment continues to outperform (refer to the graph below) driven by the urgent need for innovative care delivery in new or alternative settings and expedited recovery of demand especially for elective procedures. Global Healthcare Capital Markets Activity.

Capital 98

Capital Globalization Biotech Marketing 98

Alpha Sense BI

MAY 5, 2023

2023 so far has revealed ideal conditions for dealmaking due to valuation resets, lessened competition for deals, and new assets coming to market. Around the world, investors are favoring companies that have proven their profitability and that can demonstrate how they have successfully utilized their capital.

Biotech 97

Biotech Capital Banking Startups 97

Alpha Sense BI

NOVEMBER 17, 2023

Ultimately, these insights aren’t found in company documents, press releases or news articles, and can give you the edge in a data-driven competitive landscape. For corporations, the value of equity research lies in the detailed coverage of their company, their competitors, and how they can strategize around specific markets.

Research 105

Research Due Diligence Analysis Competitive 105

Alpha Sense BI

FEBRUARY 23, 2024

Over the last decade, the investment banking sector has been completely transformed by a myriad of factors —the mounting prevalence of digital transformation, shifting economic paradigms, and opportunities in trending areas such as sustainable finance, blockchain , RegTech, etc.

Banking 111

Banking Due Diligence Competitive Landscape Benchmarking 111

Alpha Sense BI

APRIL 29, 2024

Heading into the second half of 2024, venture capital investors remain cautious as they acknowledge persistent challenging dynamics in the landscape. While dry powder reserves have reached record highs, investors are wary about deploying capital with certain recent macroeconomic factors still fresh in mind.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

APRIL 19, 2024

2020 and 2021 were marked by increased innovation, accelerated growth, and workforce expansion. On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. As we navigate 2024, the landscape appears positioned for a triumphant comeback.

Technology 69

Technology Technology Retail Biotech 69